INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
Dr. Reddy's Laboratories enters into exclusive distribution and marketing agreement with Takeda regarding Qdenga in India (INR 1172.05, 0.00)
Dr. Reddy's Laboratories provides update on FDA assessment of its Morelos, Mexico facility with 2 observations (INR 1161.00, 0.00)
Powered by FactSet Research Systems Inc.